NEOSPHERE Trademark

Trademark Overview


On Tuesday, July 5, 2022, a trademark application was filed for NEOSPHERE with the United States Patent and Trademark Office. The USPTO has given the NEOSPHERE trademark a serial number of 97489090. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Friday, February 16, 2024. This trademark is owned by NEOsphere Biotechnologies GmbH. The NEOSPHERE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Analysis in the field of molecular biology; Consultancy relating to pharmaceutical research and development; Consultancy in the field of pharmaceutical research; Pharmaceutical product evaluation; Biochemistry research services; Biochemical analysis; Biochemistry services in the nature of mass spectrometry based proteomics and proteomic data analysis; Biochemical research and analysis; Biological analysis; Biological research and development services; Biological research; Biological research and analysis; Biological research, clinical research and medical research; Biomedical research services; Biotechnological research relating to industry; Research relating to biotechnology; Computer programming in the medical field; Computer software programming services; Medical research laboratory services; Biological research laboratory services; Services for assessing the efficiency of pharmaceuticals being testing of pharmaceuticals; Biotechnology testing; Analysis of human serum for medical re...
neosphere

General Information


Serial Number97489090
Word MarkNEOSPHERE
Filing DateTuesday, July 5, 2022
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateFriday, February 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAnalysis in the field of molecular biology; Consultancy relating to pharmaceutical research and development; Consultancy in the field of pharmaceutical research; Pharmaceutical product evaluation; Biochemistry research services; Biochemical analysis; Biochemistry services in the nature of mass spectrometry based proteomics and proteomic data analysis; Biochemical research and analysis; Biological analysis; Biological research and development services; Biological research; Biological research and analysis; Biological research, clinical research and medical research; Biomedical research services; Biotechnological research relating to industry; Research relating to biotechnology; Computer programming in the medical field; Computer software programming services; Medical research laboratory services; Biological research laboratory services; Services for assessing the efficiency of pharmaceuticals being testing of pharmaceuticals; Biotechnology testing; Analysis of human serum for medical research; Analysis of human tissues for medical research; Conducting of scientific studies and research in the field of targeted protein degradation and targeted protein stabilization and related data analysis; Development of pharmaceutical drug preparations and medicines; Development and creation of computer programmes for data processing; Computer software development for others; Development of data bases; Pharmaceutical products development; computer software development; Design and development of data processing programs; Research and development of vaccines and medicines; Research relating to molecular sciences; Research on the subject of pharmaceuticals; Research and development services in the field of immunology; Research and development in the pharmaceutical and biotechnology fields; Biochemical research and development; Research and development for the pharmaceutical industry; Research and development in the field of microorganisms and cells; Clinical research in the field of targeted protein degradation and targeted protein stabilization and related data analysis; Medical and scientific research, namely, conducting clinical trials for others; Laboratory research services relating to pharmaceuticals; Medical research; Medical research in the field of oncology; Pharmaceutical drug development services; Pharmaceutical research services; Pharmaceutical research and development; Preparation of biological samples for research purposes; Preparation of biological samples for analysis in research laboratories; Preparation of biological samples for testing and analysis in research laboratories; Scientific and technological services, namely, scientific analysis in the field of targeted protein degradation and targeted protein stabilization and related data analysis; Scientific research in the field of drug discovery; Scientific research relating to biology; Scientific research and development; Scientific research for medical purposes in the area of cancerous diseases; Scientific investigations for medical purposes

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 25, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNEOsphere Biotechnologies GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPlanegg 82152
DE

Trademark Events


Event DateEvent Description
Friday, February 16, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, August 16, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, August 16, 2023LETTER OF SUSPENSION E-MAILED
Wednesday, August 16, 2023SUSPENSION LETTER WRITTEN
Thursday, July 20, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 19, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 19, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 24, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 24, 2023NON-FINAL ACTION E-MAILED
Monday, April 24, 2023NON-FINAL ACTION WRITTEN
Wednesday, April 19, 2023ASSIGNED TO EXAMINER
Tuesday, October 11, 2022PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Tuesday, October 11, 2022ASSIGNED TO LIE
Wednesday, August 31, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, July 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 8, 2022NEW APPLICATION ENTERED